Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

An evaluation of pharmacists' expectations towards pharmacogenomics.

de Denus S, Letarte N, Hurlimann T, Lambert JP, Lavoie A, Robb L, Sheehan NL, Turgeon J, Vadnais B.

Pharmacogenomics. 2013 Jan;14(2):165-75. doi: 10.2217/pgs.12.197.

PMID:
23327577
2.

A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar.

Elewa H, Alkhiyami D, Alsahan D, Abdel-Aziz A.

J Eval Clin Pract. 2015 Aug;21(4):703-9. doi: 10.1111/jep.12372. Epub 2015 Apr 30.

PMID:
25929423
3.

Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.

Romagnoli KM, Boyce RD, Empey PE, Adams S, Hochheiser H.

Int J Med Inform. 2016 Feb;86:54-61. doi: 10.1016/j.ijmedinf.2015.11.015. Epub 2015 Nov 30.

4.

Pharmacogenomics training using an instructional software system.

Springer JA, Iannotti NV, Kane MD, Haynes K, Sprague JE.

Am J Pharm Educ. 2011 Mar 10;75(2):32.

5.

Pharmacists' expectations for entry-level practitioner competency.

Boyle M, Myford C.

Am J Pharm Educ. 2013 Feb 12;77(1):5. doi: 10.5688/ajpe7715.

6.

Pharmacogenomics in a community pharmacy: ACT now.

Padgett L, O'Connor S, Roederer M, McLeod H, Ferreri S.

J Am Pharm Assoc (2003). 2011 Mar-Apr;51(2):189-93. doi: 10.1331/JAPhA.2011.10178.

PMID:
21382809
7.

Integrating pharmacogenomics into pharmacy practice via medication therapy management.

Reiss SM; American Pharmacists Association.

J Am Pharm Assoc (2003). 2011 Nov-Dec;51(6):e64-74. doi: 10.1331/JAPhA.2011.11543.

PMID:
22001957
8.

Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.

Su C, Ji H, Su Y.

Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):217-22. doi: 10.1002/pds.1792.

PMID:
20033911
9.

Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?

Aburuz S, Al-Ghazawi M, Snyder A.

Int J Pharm Pract. 2012 Apr;20(2):71-9. doi: 10.1111/j.2042-7174.2011.00164.x. Epub 2011 Oct 13.

PMID:
22416931
10.

Assessment of the pharmacogenomics educational needs of pharmacists.

McCullough KB, Formea CM, Berg KD, Burzynski JA, Cunningham JL, Ou NN, Rudis MI, Stollings JL, Nicholson WT.

Am J Pharm Educ. 2011 Apr 11;75(3):51.

11.

Development and evaluation of a pharmacogenomics educational program for pharmacists.

Formea CM, Nicholson WT, McCullough KB, Berg KD, Berg ML, Cunningham JL, Merten JA, Ou NN, Stollings JL.

Am J Pharm Educ. 2013 Feb 12;77(1):10. doi: 10.5688/ajpe77110.

12.

Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients.

Lalonde L, Hudon E, Goudreau J, BĂ©langer D, Villeneuve J, Perreault S, Blais L, Lamarre D.

Res Social Adm Pharm. 2011 Sep;7(3):233-45. doi: 10.1016/j.sapharm.2010.05.003. Epub 2010 Jul 23.

PMID:
21272548
13.

Pharmacists as immunizers: a survey of community pharmacists' willingness to administer adult immunizations.

Edwards N, Gorman Corsten E, Kiberd M, Bowles S, Isenor J, Slayter K, McNeil S.

Int J Clin Pharm. 2015 Apr;37(2):292-5. doi: 10.1007/s11096-015-0073-8. Epub 2015 Feb 17.

PMID:
25687902
14.

Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.

Shishko I, Almeida K, Silvia RJ, Tataronis GR.

Pharmacogenomics. 2015;16(9):949-58. doi: 10.2217/pgs.15.22. Epub 2015 Jun 23.

PMID:
26100610
15.

Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada.

Abbott R, Edwards S, Whelan M, Edwards J, Dranitsaris G.

J Oncol Pharm Pract. 2014 Feb;20(1):29-39. doi: 10.1177/1078155213504975. Epub 2013 Oct 8.

PMID:
24103897
16.

The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group.

Kennedy MJ, Phan H, Benavides S, Potts A, Sorensen S.

J Pediatr Pharmacol Ther. 2011 Apr;16(2):118-22. doi: 10.5863/1551-6776-16.2.118.

17.

Medication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs.

Blake KB, Madhavan SS, Scott VG, Meredith Elswick BL.

Res Social Adm Pharm. 2009 Jun;5(2):182-8. doi: 10.1016/j.sapharm.2008.06.003. Epub 2009 Jan 21.

PMID:
19524865
18.

Physicians' perceptions and expectations of pharmacists' professional duties in government hospitals in Kuwait.

Matowe L, Abahussain EA, Al-Saffar N, Bihzad SM, Al-Foraih A, Al-Kandery AA.

Med Princ Pract. 2006;15(3):185-9.

19.

Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.

Blake KB, Madhavan SS.

Ann Pharmacother. 2010 Mar;44(3):424-31. doi: 10.1345/aph.1M386. Epub 2010 Feb 23.

PMID:
20179254
20.

Supplemental Content

Support Center